Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Rothman

Showing results (251-260 of 262) with videos related to

Pageof 27
Sort By:
Journal of Medicinal Chemistry|February 28, 1997
Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alpha R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligandsS N Calderon, K C Rice, R B Rothman, et al.
Journal of Medicinal Chemistry|September 10, 1999
Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinansS Ananthan, H S Kezar, R L Carter, et al.
Synapse (New York, N.Y.)|April 3, 1999
Opioid peptide receptor studies, 11: involvement of Tyr148, Trp318 and His319 of the rat mu-opioid receptor in binding of mu-selective ligandsH Xu, Y F Lu, J S Partilla, et al.
Synapse (New York, N.Y.)|February 5, 1998
Opioid peptide receptor studies. 7. The methylfentanyl congener RTI-4614-4 and its four enantiomers bind to different domains of the rat mu opioid receptorY F Lu, H Xu, L Y Liu-Chen, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
N-substituted octahydro-4a-(3-hydroxyphenyl)-10a-methyl-benzo[g]isoquinolines are opioid receptor pure antagonistsJ B Thomas, S W Mascarella, J P Burgess, et al.
Journal of Medicinal Chemistry|April 13, 2001
Factors influencing agonist potency and selectivity for the opioid delta receptor are revealed in structure-activity relationship studies of the 4-[(N-substituted-4-piperidinyl)arylamino]-N,N-diethylbenzamidesJ B Thomas, X M Herault, R B Rothman, et al.
Journal of Medicinal Chemistry|August 29, 1997
Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonistsY Katsura, X Zhang, K Homma, et al.
Journal of Medicinal Chemistry|October 10, 1998
N-Substituted 9beta-methyl-5-(3-hydroxyphenyl)morphans are opioid receptor pure antagonistsJ B Thomas, X Zheng, S W Mascarella, et al.
Brain Research. Molecular Brain Research|December 3, 1999
Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpressionD M Donovan, L L Miner, M P Perry, et al.
Journal of Medicinal Chemistry|August 10, 2001
Identification of the first trans-(3R,4R)- dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid kappa receptor antagonist activityJ B Thomas, R N Atkinson, R B Rothman, et al.
Pageof 27

Showing results (251-260 of 262) with videos related to

Sort By:
Pageof 27
Journal of Medicinal Chemistry|February 28, 1997
Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alpha R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligandsS N Calderon, K C Rice, R B Rothman, et al.
Journal of Medicinal Chemistry|September 10, 1999
Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinansS Ananthan, H S Kezar, R L Carter, et al.
Synapse (New York, N.Y.)|April 3, 1999
Opioid peptide receptor studies, 11: involvement of Tyr148, Trp318 and His319 of the rat mu-opioid receptor in binding of mu-selective ligandsH Xu, Y F Lu, J S Partilla, et al.
Synapse (New York, N.Y.)|February 5, 1998
Opioid peptide receptor studies. 7. The methylfentanyl congener RTI-4614-4 and its four enantiomers bind to different domains of the rat mu opioid receptorY F Lu, H Xu, L Y Liu-Chen, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
N-substituted octahydro-4a-(3-hydroxyphenyl)-10a-methyl-benzo[g]isoquinolines are opioid receptor pure antagonistsJ B Thomas, S W Mascarella, J P Burgess, et al.
Journal of Medicinal Chemistry|April 13, 2001
Factors influencing agonist potency and selectivity for the opioid delta receptor are revealed in structure-activity relationship studies of the 4-[(N-substituted-4-piperidinyl)arylamino]-N,N-diethylbenzamidesJ B Thomas, X M Herault, R B Rothman, et al.
Journal of Medicinal Chemistry|August 29, 1997
Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonistsY Katsura, X Zhang, K Homma, et al.
Journal of Medicinal Chemistry|October 10, 1998
N-Substituted 9beta-methyl-5-(3-hydroxyphenyl)morphans are opioid receptor pure antagonistsJ B Thomas, X Zheng, S W Mascarella, et al.
Brain Research. Molecular Brain Research|December 3, 1999
Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpressionD M Donovan, L L Miner, M P Perry, et al.
Journal of Medicinal Chemistry|August 10, 2001
Identification of the first trans-(3R,4R)- dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid kappa receptor antagonist activityJ B Thomas, R N Atkinson, R B Rothman, et al.
Pageof 27